Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Fetal Tissue, Stem Cells & Bioethics

137 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
137 results
featured-image
Fetal Tissue, Stem Cells & Bioethics

Backgrounder: We Need a New NIH Director

On April 25, 2017, Charlotte Lozier Institute Vice President and Director of Research, Dr. David A. Prentice, Ph.D., was published in USA Today on the need for a new National Institutes of Health (NIH) Director. The backgrounder below provides summary main points and sources on the position of current NIH Director Dr. Francis Collins in support of human embryonic stem cell research, human cloning, and the creation of ethically-questionable human-animal chimeras.

David Prentice, Ph.D.
April 25, 2017
Please login to bookmark Close
Fetal Tissue, Stem Cells & Bioethics

Q&A with the Scholars: Science, Ethics, and Fetal Tissue

Tara Sander Lee, Ph.D., is a Molecular and Cell Biologist with over 15 years of experience in academic research and healthcare. She obtained her Ph.D. in biochemistry from the Medical College of Wisconsin, followed by research fellowship training in cell and molecular biology at Harvard Medical School and Boston Children’s Hospital.

Fetal Tissue, Stem Cells & Bioethics

Q&A with the Scholars: Adult Stem Cell Treatments and Life-Saving Research

Paul Wagle, M.A., is the Director of Life Science Development for the lead economic agency in the state of Kansas. Mr. Wagle was diagnosed with leukemia at the age of 10, and after a four-year battle including an adult stem cell transplant, he has been cured for over 10 years. He holds a Master of Arts in Philosophical Studies, and serves as an advisor on two healthcare boards including the Midwest Stem Cell Therapy Center Advisory Board.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Written Testimony of Tara Sander Lee, Ph.D., in Support of Texas Bill to Prohibit Human Fetal Tissue Research

On Wednesday, February 15, 2017, the Texas Committee of Health and Human Services held a hearing regarding Texas Senate Bill 8 (SB 8). SB 8 prohibits partial-birth abortions, prohibits donation of human fetal tissue except by certain authorized facilities to accredited universities, and prohibits the purchase or sale of human fetal tissue.

Fetal Tissue, Stem Cells & Bioethics

Video: Dr. Joel McGuirk and the Adult Stem Cell Revolution

Today the Charlotte Lozier Institute releases its sixth in its series of Stem Cell Research Facts videos. This story features the work of Dr. Joseph McGuirk, an adult stem cell expert at the University of Kansas Hospital, and tells the story of Chance Runnion’s recovery from leukemia after an adult stem cell transplant.

Fetal Tissue, Stem Cells & Bioethics

Q&A with the Scholars: Science and the Beginning of Human Life

Fetal Tissue, Stem Cells & Bioethics

Q&A with the Scholars: Down Syndrome and Prenatal Testing

Mark Bradford is President of the Jerome Lejeune Foundation USA since 2012. Mr. Bradford has been researching Down syndrome-related issues and advocating for individuals with Down syndrome since his son, Thomas, was born with Down syndrome in 2001.

featured-image
Fetal Tissue, Stem Cells & Bioethics

CLI Vice Pres. Dr. Prentice on Gene-Editing: “Let Congress Know to Take It Slow”

On December 28, 2016, CLI’s Vice President and Research Director, Dr. David Prentice, co-authored an op-ed with Congressman Dr. Michael Burgess (R-Tex.) on the ethical and unethical uses of human gene editing, especially in light of the advent of the CRISPR-Cas System.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image